Can Innovation in Regulatory Science Address Health Care Cost Burdens?

Clin Pharmacol Ther. 2019 Apr;105(4):809-811. doi: 10.1002/cpt.1334. Epub 2019 Feb 10.

Authors

Gregory W Daniel¹, Morgan H Romine¹, Mark B McClellan¹

Affiliation

¹ Center for Health Policy at Duke University, Durham, North Carolina, USA.

PMID: 30739326
DOI: 10.1002/cpt.1334

No abstract available

MeSH terms

Delivery of Health Care / economics*
Diffusion of Innovation
Drug Development / economics*
Drug Industry / economics
Equipment and Supplies / economics
Health Care Costs
Humans
Organizational Innovation